The Claim
In A549 lung adenocarcinoma cells under glucose deprivation, AMPK activation is necessary for the upregulation of SLC38A2, which enables increased glutamine utilization and glycolysis, and restores metabolic function impaired by PCK2 knockdown.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human lung cancer cells deprived of glucose, AMPK activation is required to increase SLC38A2 expression, which supports greater use of glutamine and glycolysis, and reverses metabolic dysfunction caused by reduced PCK2 activity.
See the scientific wording
In A549 lung adenocarcinoma cells under glucose deprivation, activation of AMPK is necessary for the upregulation of SLC38A2 and the subsequent enhancement of glutamine utilization and glycolysis, and can rescue the metabolic defects caused by PCK2 knockdown, indicating AMPK acts as a critical intermediary in this pathway.
When glucose is scarce, a cellular energy sensor turns on and activates a transcription factor that increases the production of a glutamine transporter. More glutamine enters the cell, where it is broken down to replenish molecules needed for sugar breakdown and energy production, allowing cancer cells to keep growing even without glucose.
What the research says
1 studyWhen sugar is low, cancer cells use glutamine for energy, and this study shows that a protein called AMPK is like a switch that turns on the glutamine transporter — even if another protein (PCK2) is broken, AMPK still makes the system work.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.